Loading…

Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2A1 allele

Hyperprolactinaemia induced by D(2) dopamine receptor antagonist antipsychotic medication can result in significant health problems. To examine the role of DRD2 polymorphism on prolactin levels in patients treated with antipsychotic medication. Antipsychotic drugs with different degrees of D(2) rece...

Full description

Saved in:
Bibliographic Details
Published in:British journal of psychiatry 2004-08, Vol.185 (2), p.147-151
Main Authors: Young, Ross Mcd, Lawford, Bruce R., Barnes, Mark, Burton, Simon C., Ritchie, Terry, Ward, Warren K., Noble, Ernest P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperprolactinaemia induced by D(2) dopamine receptor antagonist antipsychotic medication can result in significant health problems. To examine the role of DRD2 polymorphism on prolactin levels in patients treated with antipsychotic medication. Antipsychotic drugs with different degrees of D(2) receptor binding were given to 144 patients with schizophrenia. Serum prolactin levels were obtained and Taq1A DRD2 alleles were determined. Prolactin levels increased across medication groups reflecting increasingly tight D(2) receptor binding (clozapine, olanzapine, typical antipsychotics and risperidone). In the combined medication group, patients with the DRD2(*)A1allele had 40% higher prolactin levels than patients without this allele. In patients treated with clozapine (the loosest D(2) receptor binding agent), patients with the DRD2(*)A1allele had prolactin levels twice those of patients without this allele. Patients with the DRD2A1 allele receiving antipsychotic medications had higher prolactin levels and were overrepresented among those with hyperprolactinaemia, suggesting greater functional D(2) receptor binding in this group.
ISSN:0007-1250
1472-1465
DOI:10.1192/bjp.185.2.147